Tertiary lymphoid structures in cancer.


Ectopic lymphoid aggregates, termed tertiary lymphoid structures (TLSs), are formed in numerous cancer types, and, with few exceptions, their presence is associated with superior prognosis and response to immunotherapy. In spite of their presumed importance, the triggers that lead to TLS formation in cancer tissue and the contribution of these structures to intratumoral immune responses remain incompletely understood. Here, we discuss the present knowledge on TLSs in cancer, focusing on (i) the drivers of TLS formation, (ii) the function and contribution of TLSs to the antitumor immune response, and (iii) the potential of TLSs as therapeutic targets in human cancers.

More about this publication

Science (New York, N.Y.)
  • Volume 375
  • Issue nr. 6576
  • Pages eabf9419
  • Publication date 07-01-2022

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.